Skip to Main Content

Paper Details

Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors.
Cancer Res
3
2022
Childhood Cancer, RVD, Restrictive Lung Defects, Restrictive ventilatory defects, cancer, childhood cancer, lung phenotype PRSs, pulmonary complications, surPRS
Author NameAffiliation
Eric D AustinVanderbilt University Medical Center
Zhaoming WangSt. Jude Children's Research Hospital
Zhaoming WangSt. Jude Children's Research Hospital
Gregory T ArmstrongSt. Jude Children's Research Hospital
Gregory T ArmstrongSt. Jude Children's Research Hospital
Gregory T ArmstrongSt. Jude Children's Research Hospital
Gregory T ArmstrongSt. Jude Children's Research Hospital
Melissa M HudsonSt. Jude Children's Research Hospital
Melissa M HudsonSt. Jude Children's Research Hospital
Leslie L RobisonSt. Jude Children's Research Hospital
Leslie L RobisonSt. Jude Children's Research Hospital
  • 1 - 11

Datasets

Release 1.2